Autoantigen estimation and simple screening assay against cardiodepressant autoantibodies in patients with dilated cardiomyopathy

Therapeutic Apheresis and Dialysis

Volumn 12, Issue 2, 2008, Pages 109-116

  Baba, Akiyasu ^a  

^a KITASATO INSTITUTE HOSPITAL   (Japan)

Author keywords

Autoantibody; Dilated cardiomyopathy; Immunoadsorption; Immunoglobulin apheresis

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); AUTOANTIBODY; AUTOANTIGEN; BETA 1 ADRENERGIC RECEPTOR; CARDIODEPRESSANT AUTOANTIBODY; CHOLINERGIC RECEPTOR; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; MUSCARINIC M2 RECEPTOR; TROPONIN I; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL TISSUE; ANTIBODY DETECTION; APHERESIS; ARTICLE; CHICK EMBRYO; CLINICAL FEATURE; CONGESTIVE CARDIOMYOPATHY; ECHOCARDIOGRAPHY; EMBRYO; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; IMMUNOADSORPTION; IMMUNOASSAY; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS;

AGED; ANIMALS; AUTOANTIBODIES; AUTOANTIGENS; CARDIOMYOPATHY, DILATED; CHICK EMBRYO; ECHOCARDIOGRAPHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMODYNAMICS; HUMANS; IMMUNOBLOTTING; IMMUNOGLOBULIN G; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; VENTRICULAR FUNCTION, LEFT;

EID: 41749116598     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2008.00555.x     Document Type: Article

References (35)

1. Baba A, Yoshikawa T, Chino M et al. Characterization of anti-myocardial autoantibodies in Japanese patients with dilated cardiomyopathy. Jpn Circ J 2001 65 : 867 73.
2. Limas C, Goldenberg IF. Autoantibodies against beta-adrenoceptors in human idiopathic dilated cardiomyopathy. Circ Res 1989 64 : 97 103.
3. Magnusson Y, Marullo S, Hoyer S et al. Mapping of a functional autoimmune epitope on the beta 1-adrenergic receptor in patients with idiopathic dilated cardiomyopathy. J Clin Invest 1990 86 : 1658 63.
4. Matsui S, Fu ML, Shimizu M et al. Dilated cardiomyopathy defines serum autoantibodies against G-protein-coupled cardiovascular receptors. Autoimmunity 1995 21 : 85 8.
5. Chiale PA, Rosenbaum MB, Elizari MV et al. High prevalence of antibodies against,1- and,2-adrenoceptors in patients with primary electrical cardiac abnormalities. J Am Coll Cardiol 1995 26 : 864 9.
6. Matsui S, Fu ML, Katsuda S et al. Peptides derived from cardiovascular G-protein-coupled receptors induce morphological cardiomyopathic changes in immunized rabbits. J Mol Cell Cardiol 1997 29 : 641 55.
7. Podlowski S, Luther HP, Morwinski R, Muller J, Wallukat G. Agonistic anti-beta1-adrenergic receptor autoantibodies from cardiomyopathy patients reduce the beta1-adrenergic receptor expression in neonatal rat cardiomyocytes. Circulation 1998 98 : 2470 6.
8. Christ T, Wettwer E, Dobrev D et al. Autoantibodies against the beta1-adrenoceptor from patients with dilated cardiomyopathy prolong action potential duration and enhance contractility in isolated cardiomyocytes. J Mol Cell Cardiol 2001 33 : 1515 25.
9. Iwata M, Yoshikawa T, Baba A, Anzai T, Mitamura H, Ogawa S. Autoantibodies against the second extracellular loop of beta1-adrenergic receptors predict ventricular tachycardia and sudden death in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 2001 37 : 418 24.
10. Fukuda Y, Miyoshi S, Tanimoto K et al. Autoimmunity against the second extracellular loop of beta(1)-adrenergic receptors induces early afterdepolarization and decreases in K-channel density in rabbits. J Am Coll Cardiol 2004 43 : 1090 100.
11. Jahns R, Boivin V, Hein L et al. Direct evidence for a beta1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy. J Clin Invest 2004 113 : 1419 29.
12. Baba A, Yoshikawa T, Fukuda Y et al. Autoantibodies against M2-muscarinic acetylcholine receptors: new upstream targets in atrial fibrillation in patients with dilated cardiomyopathy. Eur Heart J 2004 25 : 1108 15.
13. Baba A, Yoshikawa T, Ogawa S. Autoantibodies produced against sarcolemmal Na-K-ATPase: possible upstream targets of arrhythmias and sudden death in patients with dilated cardiomyopathy. J Am Coll Cardiol 2002 40 : 1153 9.
14. Okazaki T, Tanaka Y, Nishio R et al. Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice. Nat Med 2003 9 : 1477 83.
15. Wallukat G, Reinke P, Dörffel WV et al. Removal of autoantibodies in dilated cardiomyopathy by immunoadsorption. Int J Cardiol 1996 54 : 191 5.
16. Dorffel WV, Felix SB, Wallukat G et al. Short-term homodynamic effects of immunoadsorption in dilated cardiomyopathy. Circulation 1997 95 : 1994 7.
17. Felix SB, Staudt A, Dorffel WV et al. Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathy. J Am Coll Cardiol 2000 35 : 1590 8.
18. Muller J, Wallukat G, Dandel M et al. Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy. Circulation 2000 101 : 385 91.
19. Staudt A, Schaper F, Stangl V et al. Immunohistological changes in dilated cardiomyopathy induced by immunoadsorption therapy and subsequent immunoglobulin substitution. Circulation 2001 103 : 2681 6.
20. Felix SB, Staudt A, Landsberger M et al. Removal of cardiodepressant antibodies in dilated cardiomyopathy by immunoadsorption. J Am Coll Cardiol 2002 39 : 646 52.
21. Staudt A, Böhm M, Knebel F et al. Potential role of autoantibodies belonging to the immunoglobulin G-3 subclass in cardiac dysfunction among patients with dilated cardiomyopathy. Circulation 2002 106 : 2448 53.
22. Staudt A, Staudt Y, Dörr M et al. Potential role of humoral immunity in cardiac dysfunction of patients with suffering from dilated cardiomyopathy. J Am Coll Cardiol 2004 44 : 829 36.
23. Richardson P, McKenna W, Bristow MR et al. Report of the 1995 World Health Organization/International Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies. Circulation 1996 93 : 841 2.
24. Sugiyama T, Miyazaki H, Saito K, Shimada H, Miyamoto K. Chick embryos as an alternative experimental animal for cardiovascular investigations: stable recording of electrocardiogram of chick embryos in ovo on the 16th day of incubation. Toxicol Appl Pharmacol 1996 138 : 262 7.
25. Staudt A, Dörr M, Staudt Y et al. Role of immunoglobulin G3 subclass in dilated cardiomyopathy: results from protein A immunoadsorption. Am Heart J 2005 150 : 729 36.
26. Zwaka TP, Manolov D, Ozdemir C et al. Complement and dilated cardiomyopathy: a role of sublytic terminal complement complex-induced tumor necrosis factor-alpha synthesis in cardiac myocytes. Am J Pathol 2002 161 : 449 57.
27. Baba A, Murayama A, Wakabayashi Y. Identification of beneficial absorbers for immunoadsorption in Japanese patients with dilated cardiomyopathy (in Japanese article). Jpn J Apher 2004 23 : 101 2.
28. Fu ML. Anti-peptide antibodies against an autoimmune epitope on human muscarinic receptor mimic functional autoantibodies against the same epitope in patients with idiopathic dilated cardiomyopathy. Eur Heart J 1995 16 : 89 91.
29. Magnusson Y, Wallukat G, Waagstein F, Hjalmarson A, Hoebeke J. Autoimmunity in idiopathic dilated cardiomyopathy: characterization of antibodies against the beta1-adrenoceptor with positive chronotropic effect. Circulation 1994 89 : 2760 7.
30. Iwata M, Yoshikawa T, Baba A et al. Autoimmunity against the second extracellular loop of beta(1)-adrenergic receptors induces beta-adrenergic receptor desensitization and myocardial hypertrophy in vivo. Circ Res 2001 88 : 578 86.
31. Maack C, Böhm M, Vlaskin L et al. Partial agonist activity of bucindolol is dependent on the activation state of the human beta1-adrenergic receptor. Circulation 2003 108 : 348 53.
32. Maack C, Tyroller S, Schnabel P et al. Characterization of beta(1)-selectivity, adrenoceptor-G(s)-protein interaction and inverse agonism of nebivolol in human myocardium. Br J Pharmacol 2001 132 : 1817 26.
33. Maack C, Cremers B, Flesch M, Hoper A, Sudkamp M, Bohm M. Different intrinsic activities of bucindolol, carvedilol and metoprolol in human failing myocardium. Br J Pharmacol 2000 130 : 1131 9.
34. Gong H, Sun H, Koch WJ et al. Specific beta(2) AR blocker ICI 118,551 actively decreases contraction through a G(i)-coupled form of the beta(2) AR in myocytes from failing human heart. Circulation 2002 105 : 2497 503.
35. Jahns R, Boivin V, Siegmund C, Inselmann G, Lohse MJ, Boege F. Autoantibodies activating human beta1-adrenergic receptors are associated with reduced cardiac function in chronic heart failure. Circulation 1999 99 : 649 54.